Multimodal imaging of foveoschisis and macular pseudohole associated with gyrate atrophy: a family report

Gyrate atrophy (GA) of choroid and retina is a rare disease with recessive autosomal transmission [1]. It is a metabolic disorder secondary to a congenital deficit in ornithine-δ-aminotransferase (OAT) causing hyperornithinemia. With an unknown mechanism, high levels of ornithine lead to a progressive chorioretinal atrophy [2, 3]. Patients with GA initially complain of night blindness and decreasing of peripheral vision typically in the second decade of life. Loss of central vision can occur in the fourth or the fifth decades.

Ophthalmological manifestations such as high myopia, marked astigmatism and early cataract formation are common [4]. Macular involvements can be due to macular edema, choroidal neovascularisation, macular hole and unfrequently foveoschisis and epiretinal membrane [5]. Two cases of foveoschisis and no case of macular pseudohole associated with GA, were reported [6, 7].

Here, we report the results of multimodal imaging of a biochemically confirmed case of a family with GA associated with foveoschisis and macular pseudohole. To our knowledge, this is the first report of GA imaged by optical coherence tomography angiography (OCTA) in the indexed peer-reviewed literature.

A 26 year-old and a 30-year-old Caucasian sisters presented to us with progressive bilateral decreased vision. There was no history of consanguineous marriage.

Gyrate atrophy is a recessive autosomic disease affecting the OAT whose deficiency causes elevation of ornithine. The initial lesion is located on the pigmentary epithelium causing atrophy of the photoreceptors [8, 9]. In GA, by the age of 10, gradual blurred vision starts, becomes severe in the fourth or fifth decade. Rare and fine hair, mental retardation associated with diffuse cerebral atrophy and muscle damage, are the most described systemic manifestations [10].

Described macular involvements in GA are pigment epithelial window defects, patches of chorioretinal atrophy, cystoid macular edema, epimacular membrane and choroidal neovascularization [4, 5, 11].

Foveoschisis is a rare association with GA. To the best of our knowledge, this is the third report of this association [6, 7]. There were no previous reports of OCTA in GA. In case 1, the aspect of intra retinal cysts on SS-OCT and the absence of leak at macula at the late phase of FA was suggesting foveoschisis rather than cystoid macular edema.

Foveoschisis corresponds to the splitting of the inner retinal layers at the macula. In high myopia, foveoschisis is probably related to vitreoretinal interface factors, to a progressive ectasia of the sclera and a relative resistance to a stretch of the inner retinal layers and the retinal vessels [12, 13]. In X-linked retinoschisis, mutations in the RS1 gene cause a loss of functional retinoschisin which disturbs the cellular organization of the retina and structure of the photoreceptor-bipolar synapse [14]. In GA, the pathogenesis of the foveoschisis is poorly understood. OAT activity is reported to be high in the retinal pigment epithelium which can explain that the initial lesion in GA is located on the pigmentary epithelium causing atrophy of the photoreceptors [8, 9]. So we can hypothesize that deficiency of essential products or toxicity of the accumulated excessive substrates, causing the chorioretinal degeneration in GA, may also disturb regulation of the fluid balance between the intracellular and extracellular environment. The extracellular fluid with cystic cavities causes disruption of the organized layers of the retina particularly within the photoreceptor and bipolar cell layers. However, pathogenesis of the foveoschisis in gyrate atrophy is probably multifactorial and can be related to vitreoretinal interface factors and to high myopia as in our patient [12]. Nevertheless, high myopia is not always involved, as Tekin et al. described a case of foveoschisis associated with GA in low myopia [7].

The OCTA showed in our case some perifoveal microvascular alterations located in the deep capillary plexus which can be either a cause or a consequence of the foveoschisis. Starga et al. found similar macular lesions in cases of X-linked retinoschisis [15].

Further studies with OCTA imaging need to be performed to better define the pathogenesis of foveoschisis in GA.

Epiretinal membrane is also a rare association with GA [16]. To the best of our knowledge, we report the first case of macular pseudohole imaged and published. Regarding its pathogenesis, several factors including aging, posterior vitreous detachment and genetic factors have been suggested to play a role in epiretinal membrane formation. In our case, the patient was young and macular pseudohole aspect was unusual as external retinal layers were disorganised and poorly individualized at the base of the pseudohole. This aspect must be distinguished from full-thickness macular hole, which has been also reported as a rare finding in GA [17].

In the treatment of GA, a low-protein diet, but sufficient for normal growth, is recommended. An arginine-free diet, if strictly obeyed, may decrease ornithine to normal levels but only 20% of patients are reported to tolerate this diet [18]. Oral B6 supplementation is administered in order to decrease serum ornithine level with a clinical heterogeneity in responsiveness [19]. Recently, Heller et al. reported for the first time an improvement of central macular edema with low protein intake and pyridoxine supplement [20]. However, treatment effect on foveoschisis is still unknown. In our patient, a longer follow-up period is needed to evaluate the long-term treatment effect.

Association of GA with foveoschisis and macular pseudohole is rare but may increase the risk of rapid vision loss. The recent widespread clinical use of optical coherence tomography has better defined characteristics of macular abnormalities in GA. OCTA is an interesting imaging tool that can help to better understand the pathophysiological mechanism of macular involvements in GA.